Mapping T and B cell epitopes in sperm protein 17 to support the development of an ovarian cancer vaccine

Xiang, S, Gao, Q, Wilson, K, Heyerick, A and Plebanski, M 2015, 'Mapping T and B cell epitopes in sperm protein 17 to support the development of an ovarian cancer vaccine', Vaccine, vol. 33, no. 44, pp. 5950-5959.

Document type: Journal Article
Collection: Journal Articles

Title Mapping T and B cell epitopes in sperm protein 17 to support the development of an ovarian cancer vaccine
Author(s) Xiang, S
Gao, Q
Wilson, K
Heyerick, A
Plebanski, M
Year 2015
Journal name Vaccine
Volume number 33
Issue number 44
Start page 5950
End page 5959
Total pages 10
Publisher Elsevier Ltd
Abstract Ovarian cancer (OC) is the seventh most common cancer in women worldwide, and the leading cause of death from gynaecological malignancy. Immunotherapeutic strategies including cancer vaccines are considered less toxic and more specific than current treatments. Sperm surface protein (Sp17) is a protein aberrantly expressed in primary as well as in metastatic lesions in >83% of ovarian cancer patients. Vaccines based on the Sp17 protein are immunogenic and protective in animal models. To map the immunogenic regions and support the development of human Sp17 peptide based vaccines, we used 6 overlapping peptides of the human Sp17 sequence adjuvanted with CpG to immunise humanised HLA-A2.1 transgenic C57BL/6 mice, and assessed immunogenicity by ELISPOT and ELISA. No CD8 T cells were found to be induced to a comprehensive panel of 10 HLA-A2.1 or H-2K(b) binding predicted epitopes. However, one of the 6 peptides, hSp17111-142, induced high levels of antibodies and IFN-γ producing T cells (but not IL-17 or IL-4) both in C57BL/6 and in C57BL/6-HLA-A2.1 transgenic mice. C57BL/6 mice immunised with CpG adjuvanted hSp17111-142 significantly prolonged the life-span of the mice bearing the ovarian carcinoma ID8 cell line. We further mapped the immuno-dominant B and T cell epitope regions within hSp17111-142 using ELISPOT and competition ELISA. Herein, we report the identification of a single immuno-dominant B cell (134-142 aa) epitope and 2 T helper 1 (Th1) cell epitopes (111-124 aa and 124-138 aa). These result together support further exploration of hSp17111-142 peptide formulations as vaccines against ovarian cancer.
Subject Immunology not elsewhere classified
Keyword(s) Antibody
B cell epitopes
CD8 epitopes
Overlapping peptides
Sperm protein 17 (Sp17)
DOI - identifier 10.1016/j.vaccine.2015.07.094
Copyright notice © 2015 Elsevier Ltd. All rights reserved.
ISSN 0264-410X
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 4 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Altmetric details:
Access Statistics: 7 Abstract Views  -  Detailed Statistics
Created: Thu, 06 Dec 2018, 10:39:00 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us